These are the details for the profile Agents and commercial agents sought for ultrasensitive assay and bio-analytical services .
If you would like more information about the profile please click Request More
Information. You will be directed to a new page where you will need
to provide some information about yourself/your business cooperation needs and submit
your expression of interest in the profile . A Network Partner will then contact
you to discuss your interest in greater detail.
A Dutch company has developed an ultrasensitive bioanalytical assay to measure innovative medicines at ultralow levels in biological fluids and tissues. The company is looking for commercial agents and distributors in order to disseminate this product in European Union countries.
A Dutch company is specialized in the analysis of innovative medicines, such as proteins, peptides, oligonucleotides and nanomedicines. They have developed a novel bioanalytical assay, which enables the measurement of innovative medicines at ultralow levels in biological fluids and tissues. The assay is up to a factor 1.000 more sensitive than conventional techniques and can be applied in toxicokinetic, pharmacokinetic, micro-dose and ADME studies in an early stage of drug research and development. The company is looking for commercial agents or partners among analytical laboratories in order to expand its business and distribute its products and services in the European market, especially Germany, Switzerland, France, Italy, Scandinavia
The technology is based on proprietary methods
for labelling of biologicals and sample preparation
and subsequently ultra sensitive measurements
by mass spectrometry. Newly developed drugs
can be tested for their pharmacokinetic profile in
pre-clinical (animal) studies or phase 0 (human)
The company seeks agents and commercial partners familiar with the pharma, biotech and life sciences market in their region to proactively develop sales.
This product and procedure is on the market and is extensively applied in the toxicokinetic and pharmacokinetic market.